Clinical Trial Update: Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide in newly diagnosed multiple myeloma; completed with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)
• low-dose dexamethasone (dexamethasone)
• melphalan, prednisone, thalidomide regimen

Snippet

Sponsor: Celgene | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2017-08-11